Search results
Showing results for
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
ASCEND grant development workshop poster
ASCEND grant development workshop poster
ASCEND grant development workshop poster digital v1.02 2.pdf (2 MB)
NDS Away Day 2026 Programme
NDS Away Day 2026 Programme
Oxford Pancreatic Cancer Research Networking Day poster.pdf
Oxford Pancreatic Cancer Research Networking Day poster